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The process of specific immunity formation wi th enteroviral infections is 
complex and insufficiently clarified. I t is supposed that the course of the latter 
is determined to a great extent by the immune status of the organism. According 
to some authors ( 1 , 2) secretory antibodies play an important but transitory role 
in the defence of the organism against polioviral infection of the digestive tract. 
Serum virus-neutralizing antibodies are the basis of a reliable and long enough 
defence against paralytic forms, indeed. 
• The purpose of the present study was to determine the level of virus-neutra-
l iz ing antibodies ( V N A ) against poliovirus type 3 wi th different genetic characte-
ristics which circulated recently more frequently among the inhabitants of V a r n a 
ci ty and caused diseases with paralyt ic manifestations in spite of systemically 
performed prophylaxis by using vaccine against poliomyelitis. 
Material and methods 
During the period from 1977 t i l l 1982 a total of 180 cases with suggested en-
teroviral infection were studied. I n the present paper only 8 of them were discus-
sed including mainly children up to 8 years old with central and peripheric ner-
vous system affections. Various cell cultures were used to isolate and typify the 
viruses. The genetic characteristics of polioviruses was established by means of 
antigen, temperature and plaque markers (1—3). Serum V N A level was determin-
ed on the same cultures by testing the I s t and I I n d serum samples. 
Results and discussion 
I t can be seen on table 1 that polioviruses type 3 with pertaining to virulent,, 
intermediary and vaccinal variat ions according to genetic markers were isolated 
from various materials mainly from cerebrospinal f luid. The case No 8/81 was a 
six-months old suckling without immunization wi th l ive poliovaccine ( L P V ) 
presented with the picture of paralyt ical poliomyelitis. We isolated a v i rulent 
poliovirus type 3 from the liquor and L P V titre increased more than fourfold in 
the second serum sample ( I s t 1:32, I I n d above 1:128). According to M. K . Voroshi-
lova (1) L P V titre increase could not be considered absolutely determing the etio-
logical role of polioviral agent because sometimes these titres were-not higher 
than that against the other poliovirus types acquired by means of immunization 
or latent infection. In our case V N A level against poliovirus type 1 and type 2 was 
< 
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T a b l e 1 
Virological and serological studies of patients with affections of the central 
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C S F virulent 1:8 yes 
C S F virulent 1:8 1:8 yes 
C S F virulent under 1:8 1:16 yes 
















between 1:8 and 1:16 while no V N A against enterovirus 71 could be established. 
I t was known that blockade of virus transmission to the central nervous system 
did not require demonstratively high V N A titres and that only blood traces of 
them could prevent viremia ( 1 , 6, 10). I n our cases in spite of V N A presence a 
polioinfection developed which was most probably determined by the part icular 
virulence of the v i r a l strain. 
The next patient, No 43/80, two-months old suckling, without L P V immuni­
zation, had polio-like disease and suspicion on paralyt ical poliomyelitis. The 
poliovirus type 3 isolated from the cerebrospinal fluid pertained genetically to 
the vaccinal variat ion. Serum V N A against polioviruses type 3 was under 1:8 in 
I s t and 1:16 in I I n d samples. There were no V N A against polioviruses type 1 and 
2 as well as against enterovirus 71 . According to other investigators ( 1 , 2, 8} 
accinal poliovirus type 3 possesses weakened immunogenicity and the develop-
ent of most cases wi th paralyt ical manifestations in immunized and contact 
ndividuals is probably due to this poliovirus type. Concerning this patient, 
resent serum conversion, poliovirus isolation from the cerebrospinal f luid, the 
ge and the c l inical picture allows us to accept the etiological role of the isolated 
gent in spite of its genetic characteristics. Next two cases, No 1/79 and No 18/80 
resent infants aged 15 and 14 months, respectively, immunized wi th L P V and 
wi th serous meningitis and polio-like disease, respectively. Polioviruses type 
3 virulent according to genetic markers were isolated from their cerebrospinal 
f luid. V N A level in both serum samples of these patients was 1:8. Most l ike ly , 
cases with insufficiently intensive humoral immunity against poliovirus type 
3 despite specific prophylaxis are considered. The confrontation with a virulent 
s t ra in caused central nervous system affections and paralyt ical manifestations. 
According to A . B . Sabin (9) specific V N A in polioinfection are formed before 
complete c l in ica l manifestation which makes the lack of seroconversion in some 
patients possible. This is a probable explanation of the fact that in well outlined 
• 
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cl inical picture (as in the aforementioned cases) there are no changes of V N A le­
vel in the course of the infection. 
There was a fourfold V N A increase in the I I n d sample ( I s t under 1:8, I I n d 1:16) 
against virulent poliovirus type 3 isolated from the liquor in patient No 11/81, 
age 17 years, wi th meningoencephalitis. The lack of specific V N A in the I s t serum 
sample gives an evidence that there is no formed immune response before infec­
tion to poliovirus type 3 although only as consequence of so-called "home immuni­
zation" and of latent infection serum V N A should be already present. I n a patient, 
No 16/81 aged 14 years wi th encephalitis, poliovirus type 3 was isolated from the 
liquor and characterized to be an intermediary variat ion. The serologic examina­
tion showed that V N A level was in I s t serum under 1:8 and in the I I n d one — 1:8. 
There was no any active V N A formation as response to antigenic stimulus of po­
liovirus type 1 and 2, too. 
Last two patients as it can be seen on table 1 (No 21/80 and 10/81) had se­
rous meningitis and encephalitis, respectively without evidence of myelopathy. 
Vaccina l polioviruses type 3 were isolated from faecal samples and nose-throat 
smears. In the first patient there was a fourfold V N A increase in the I I n d serum 
which was probably due to the regular L P V immunization. I n the second patient 
there were no specific V N A against poliovirus type 3 in both sera tested but the 
parallelly isolated virus strain Coxackie B l could be determined as an etiological 
agent. 
We draw the following conclusions: 
Despite regularly performed specific prophylaxis there are low V N A titres 
against poliovirus type 3 in patients wi th central and peripheric nervous system 
affections. Our investigations do not confirm the concept of some authors that 
even V N A traces in the serum only could prevent poliovirus infection by polio­
v i r u s type 3 as an etiological agent. The titres of V N A in I s t serum sample (be­
tween 1:8 and 1:16) in single patients did not prove to be sufficient barrier for 
prevention of infection of the nervous system. Independently of their genetic 
characteristics the polioviruses type 3 isolated by us do not induce in most cases 
an active V N A formation which results in development of a neuroinfection. The 
establishing of the etiological role of vaccinal strain poliovirus type 3 in cases 
of polio-like disease is a serious signal for strengthening the systemic control ( v i -
rological, immunological and epidemiological) on performed L P V immunization 
and the quality of vaccine itself. 
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О СОЗДАНИИ ВИРУСНЕЙТРАЛИЗИРУЮЩИХ АНТИТЕЛ ПО ОТНОШЕНИЮ 
К ПОЛИОВИРУСАМ I I I ТИПА ПРИ ЗАТРАГИВАНИИ ЦЕНТРАЛЬНОЙ 
И ПЕРИФЕРИЧЕСКОЙ НЕРВНОЙ СИСТЕМЫ 
В . Евтимова 
Р Е З Ю М Е 
Прослеживается образование вируснейтрализирующих антител у больных, преимуще­
ственно в возрасте до восьми лет, с затрагиванием центральной и периферической нервной 
системы. На тканевых культурах, взятых у тех же больных, изолированы из ликвора полио-
вирусов I I I типа с различной генетической характеристикой. Установлена этиологическая 
роля как вирулентных, так и вакцинальных полно I I I , что является фактом, имеющим осо­
бое клиническое и эпидемиологическое значение. 
Полученные результаты говорят о необходимости в систематических исследованиях 
:порадических случаев заболевания с затрагиванием нервной системы. 
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